3D Systems Corp - DDD STOCK NEWS

3D Systems (NYSE: DDD) announced it will release its first quarter 2023 financial results after the U.S. markets close on May 8, 2023. The company will host a conference call to discuss these results on May 9, 2023, at 8:30 a.m. Eastern Time. Investors can join the discussion via webcast or by telephone at 201-689-8345. A replay of the call will be available about two hours after its conclusion. 3D Systems continues to position itself as a leader in additive manufacturing, servicing markets such as healthcare, automotive, and aerospace with its innovative solutions.

Systemic Bio, a subsidiary of 3D Systems (NYSE:DDD), has announced the opening of a new 15,000 sq. ft. facility in Houston's TMC Innovation Factory Labs. This state-of-the-art location is dedicated to the R&D and production of the h-VIOS™ organ-on-a-chip platform, which allows for the testing of pharmaceutical drugs using human cells. The facility features cleanroom manufacturing to support sterile production and aims to fulfill multiple contracts with pharmaceutical companies over the next year. Jeremy Carter joins as Vice President of Operations to oversee this new venture, which marks a significant milestone in Systemic Bio’s drug discovery initiatives.

3D Systems (NYSE: DDD) has partnered with TE Connectivity to develop an innovative additive manufacturing solution for producing electrical connectors that meet stringent UL regulatory standards. The collaboration introduces a novel photopolymer that allows for production within weeks, significantly reducing lead times compared to traditional methods. This first-ever UL-recognized photopolymer has passed long-term thermal aging tests, displaying exceptional properties such as a flammability rating of UL94 V0 at 0.4mm thickness. With this new technology, TE Connectivity can efficiently produce complex geometries and adapt to low-volume production demands, enhancing its competitive edge in the market.

3D Systems announced major enhancements to its digital dentistry portfolio with the introduction of innovative materials, NextDent Base and NextDent Cast, designed for improved mechanical properties. The NextDent LCD1 printer, a compact and user-friendly device, is now available, enabling clinics to adopt 3D printing to enhance efficiency and patient experience. NextDent Base is a third-generation denture base material with high break resistance and aesthetic options, while NextDent Cast offers easy burn-out features for various dental applications. These products aim to streamline workflows and improve results in dental practices.

3D Systems (NYSE:DDD) has launched VSP Connect, a cloud-based surgical planning portal that integrates automated workflows and AI technologies to enhance collaboration and efficiency in patient-specific surgeries. Powered by Enhatch, VSP Connect aims to reduce planning times, improve communication between stakeholders, and streamline the preoperative process. The platform provides real-time patient case visualization, facilitating compliance and traceability in surgical planning. With over 150,000 patient-specific cases planned and more than 2 million implants manufactured, 3D Systems continues to lead in personalized healthcare solutions.

3D Systems Corporation (NYSE:DDD) reported a Q4 2022 revenue of $132,732, down 12.0% year-over-year, influenced by weakness in the dental orthodontics market. The full-year revenue was $538,031, reflecting a 12.6% decline from 2021. The company posted a net loss of $25,553 in Q4, totaling $122,711 for the year, leading to diluted losses of $0.20 and $0.96 per share respectively. Despite challenges, the company anticipates mid-single digit revenue growth in 2023, supported by strong performance in Industrial and Healthcare segments. The company projects Adjusted EBITDA to break even or better and maintains a robust cash position of $568,737.

3D Systems (NYSE: DDD) announced a restructuring initiative aimed at enhancing operational efficiencies. This initiative includes optimizing European metal printer operations and streamlining software organization, expected to cut operating expenses by $2.5 million to $3.5 million in 2023, and annual savings of $5.5 million to $7.0 million from 2024 onwards. The engineering and manufacturing consolidation of metal printers aims to improve product introduction cycles. Additionally, the merger of software development structures will yield cost savings through integration. Activities will commence immediately and conclude by mid-2023, reinforcing 3D Systems' commitment to operational excellence.

3D Systems (NYSE: DDD) announced that BWT Alpine F1 Team has purchased four SLA 750 3D printing systems to enhance productivity and part quality in its operations. This acquisition allows the team to produce 25,000 parts annually, significantly improving wind tunnel testing models using 3D Systems’ Accura Composite PIV material. The SLA 750 systems were chosen after rigorous testing, demonstrating superior print quality and efficiency. BWT Alpine F1 Team highlighted the systems' ability to reduce build times while maintaining high geometric accuracy and surface quality, ultimately accelerating innovation and design iteration.

3D Systems (NYSE: DDD) has announced the launch of its Regenerative Tissue Program, focusing on developing bioprinted human tissues for various surgical applications. The program leverages the company’s expertise in solid organ development and advanced bioprinting technology. The initial product targets patient-specific regenerative breast tissue (RBT™), addressing the growing need for long-term solutions for breast reconstruction among cancer survivors. With a focus on high-resolution scaffolds and patient-derived cells, 3D Systems aims to improve surgical outcomes and elevate patient experiences. This program builds on over a decade of collaboration with surgeons and extensive research in tissue regeneration.